Returns Overview

1 Month
+4.98%
3 Months
+6.07%
6 Months
+9.14%
YTD
+6.98%
1 Year
+38.51%
3 Years
+12.52%
5 Years
+7.66%

Risk Metrics (1-Year)

No risk data available for this ETF

Stress Test Scenarios

How would FTXH have held up?
🦠COVID-19 Crash33 days
Market peak to trough during pandemic sell-off
Run Analysis
📈2022 Rate Hikes9 months
Fed aggressive rate hiking cycle bear market
🔒Upgrade to run
📉2018 Q4 Selloff3 months
Trade war fears and Fed tightening
🔒Upgrade to run
🏦SVB / Banking Crisis5 days
Regional banking contagion fears
🔒Upgrade to run

1 Month Performance

+4.98%

3 Months Performance

+6.07%

6 Months Performance

+9.14%

1 Year Performance

+38.51%

Benchmark & Peers

Benchmark
Nasdaq US Smart Pharmaceuticals Index(NQSSPH)
This ETF (YTD)
+6.98%
Peer Avg (YTD)
+1.69%
vs Peers
+5.29%

FTXH ETF Performance

FTXH performance across multiple time periods: 1-month 4.98%, YTD 6.98%, 1-year 38.51%, 3-year 12.52%, 5-year 7.66%.

FTXH returns outperform the peer average of 1.69% YTD. With an expense ratio of 0.60%, investors should weigh costs against performance when evaluating this ETF.

FTXH performance comparison shows side-by-side returns with another fund. FTXH alternatives are available in the ETF Screener.

Performance & Returns

Loading chart...

Performance Returns

PeriodTotal ReturnDate Range
1 Month+4.98%May 18, 2026 to Jun 18, 2026
3 Months+6.07%Mar 18, 2026 to Jun 18, 2026
6 Months+9.14%Dec 18, 2025 to Jun 18, 2026
1 Year+38.51%N/A
3 Years+12.52%N/A
5 Years+7.66%N/A

All returns shown are total returns, not annualized